NSun2 Deficiency Protects Endothelium From Inflammation via mRNA Methylation of ICAM-1

Yuhong Luo1, Juan Feng1, Qingbo Xu1

  • 1From the Department of Physiology and Pathophysiology, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Peking University Health Science Center, Beijing, P.R. China (Y.L., J.F., X.W.); Cardiovascular Division, BHF Centre for Vascular Regeneration, King's College London, United Kingdom (Q.X.); and Department of Biochemistry and Molecular Biology, Beijing Key Laboratory of Protein Posttranslational Modifications and Cell Function, Peking University Health Science Center, Beijing, P.R. China (W.W.).

Circulation Research
|February 4, 2016
PubMed
Abstract

Insights

The enzyme NSun2 (NOP2/Sun domain family, member 2) upregulates ICAM-1 expression by methylating its mRNA, promoting vascular inflammation and arteriosclerosis. This NSun2-ICAM-1 pathway is a key regulator in vascular disease progression.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Immunology

Background:

  • Vascular endothelial inflammation is critical in cardiovascular diseases.
  • Intercellular adhesion molecule 1 (ICAM-1) expression is a key marker.
  • Mechanisms regulating ICAM-1 remain largely undefined.

Purpose of the Study:

  • To elucidate the role of NSun2 (NOP2/Sun domain family, member 2) in ICAM-1 regulation via mRNA methylation.
  • To investigate the impact of the NSun2-ICAM-1 pathway on vascular inflammation.
  • To assess the NSun2-ICAM-1 process in allograft arteriosclerosis.

Main Methods:

  • In vitro, cellular, and in vivo methylation assays were employed.
  • tRNA methyltransferase NSun2's role in ICAM-1 mRNA methylation was analyzed.
  • Experiments utilized wild-type and NSun2(-/-) rats, including an aortic allograft model.

Main Results:

  • NSun2 directly methylated ICAM-1 mRNA, enhancing its translation and leukocyte adhesion.
  • Tumor necrosis factor-α and homocysteine activated NSun2 by inhibiting Aurora-B phosphorylation.
  • NSun2 deficiency significantly reduced ICAM-1 induction, leukocyte adhesion, and allograft arteriosclerosis.

Conclusions:

  • NSun2 acts as a key regulator, upregulating ICAM-1 expression through mRNA methylation.
  • The NSun2-mediated ICAM-1 pathway is integral to vascular inflammation.
  • Targeting NSun2 may offer therapeutic strategies for vascular diseases and transplant arteriosclerosis.